Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
2015; Oxford University Press; Volume: 212; Issue: 8 Linguagem: Inglês
10.1093/infdis/jiv194
ISSN1537-6613
AutoresTodd T. Brown, Carlee Moser, Judith S. Currier, Heather J. Ribaudo, Jennifer Rothenberg, Theodoros Kelesidis, Otto O. Yang, Michael P. Dubé, Robert L. Murphy, James H. Stein, Grace A. McComsey,
Tópico(s)HIV/AIDS drug development and treatment
ResumoBackground. Specific antiretroviral therapy (ART) medications and the severity of human immunodeficiency virus (HIV) disease before treatment contribute to bone mineral density (BMD) loss after ART initiation.
Referência(s)